• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Restricted Flow rate (1248)
Patient Problems Headache (1880); Stenosis (2263)
Event Type  Injury  
Event Description
Information received from the article: ding et al.Endovascular treatment of recurrent intracranial aneurysms following previous microsurgical clipping with the pipeline embolization device.Journal of clinical neuroscience.21 (2014), 1241-1244.Medtronic (covidien) received information regarding a manufactured product and adverse event through literature review.Treatment of a large fusiform aneurysm located in the supraclinoid segment of the right ica (internal carotid artery).The patient underwent pipeline embolization treatment without any issues.At seven months, angiography revealed complete aneurysm obliteration with moderate in-stent stenosis.At eleven months, angiography showed complete resolution of the in-stent stenosis without evidence of residual aneurysm however the patient was experiencing chronic headaches and was neurologically stable.The article emphasized the importance of close angiographic surveillance after aneurysm treatment, even in patients who have undergone microsurgical clipping.
 
Manufacturer Narrative
The report was created to capture the in-stent stenosis.The information was received from the article: ding et al.Endovascular treatment of recurrent intracranial aneurysms following previous microsurgical clipping with the pipeline embolization device.Journal of clinical neuroscience.21 (2014), 1241-1244.The lot history record review was not possible since the lot number was not reported.The device will not be returned as it was implanted in the patient.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key4541897
MDR Text Key5353146
Report Number2029214-2015-00195
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 01/26/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/24/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/26/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age45 YR
-
-